Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Employer
-
Field
-
augmented by a campus on the Queen Elizabeth Olympic Park. The UCL Faculty of Engineering is the largest of its kind in the UK, ranked as the second most impactful engineering faculty in Europe and first for
-
colleagues from the Massachusetts Institute of Technology (MIT), University College London (UCL), The Polytechnic University of Hong Kong, The University of Edinburgh, Stanford University, Erasmus University
-
to work scheme and season ticket loan Immigration loan Relocation scheme for certain posts On-Site nursery On-site gym Visit https://www.ucl.ac.uk/work-at-ucl/reward-and-benefits to find out more. Customer
-
: https://www.ucl.ac.uk/bartlett/energy/research/shipping and www.shippingandoceans.com UCL is part of a consortium of eight universities leading on the maritime component of TransiT, a new UK research hub
-
Electrodes (Nextrode). This project brings together lithium-ion electrode manufacturing expertise from Universities across the UK (Oxford, Birmingham, Warwick, Southampton and UCL). As Research Associate in
-
nationalities represented in a student body of 43,800 students. Our main location in Central London has recently been augmented by a campus on the Queen Elizabeth Olympic Park. The UCL Faculty of Engineering is
-
nationalities represented in a student body of 43,800 students. Our main location in Central London has recently been augmented by a campus on the Queen Elizabeth Olympic Park. The UCL Faculty of Engineering is
-
Social and Historical Sciences. For more information, please visit http://www.ucl.ac.uk/about UCL Mechanical Engineering UCL Mechanical Engineering has been pioneering the development of engineering
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and